Mount Sinai Health System

Mount Sinai Health System is a major integrated healthcare network anchored in New York City. Formed through a significant merger, it encompasses a renowned medical school, multiple acute-care hospitals, and a vast network of ambulatory practices. The system is consistently ranked among the nation's top hospitals by U.S. News & World Report and is a powerhouse in biomedical research and graduate medical education.

History

The system was formally created in 2013 through the merger of Continuum Health Partners and the Mount Sinai Medical Center. This landmark consolidation brought together historic institutions including Beth Israel Medical Center, St. Luke's-Roosevelt Hospital Center, and the original Mount Sinai Hospital, which was founded in 1852. Key figures in its development include Dr. Kenneth L. Davis, who served as CEO, and the leadership of the Icahn School of Medicine at Mount Sinai. Earlier expansions included affiliations with institutions like New York Eye and Ear Infirmary and the acquisition of Queens Hospital Center services.

Hospitals and facilities

The system's core comprises several major hospitals, including the flagship Mount Sinai Hospital on the Upper East Side, Mount Sinai Morningside, Mount Sinai West, and Mount Sinai Beth Israel. It also operates the Mount Sinai Kravis Children's Hospital and specialty facilities such as the Mount Sinai Heart and the Dubin Breast Center. Significant campuses are located in Queens and Brooklyn, with an extensive network of over 400 ambulatory practice locations throughout the New York metropolitan area. The system's main research hub is the Icahn Medical Institute building.

Medical education and research

The system's academic core is the Icahn School of Medicine at Mount Sinai, a highly selective institution known for innovative programs like its FlexMed early admission pathway. It is a major recipient of funding from the National Institutes of Health and houses renowned research institutes such as the Mount Sinai Center for Transformative Disease Modeling and the Nash Family Department of Neuroscience. The system sponsors over 200 residency and fellowship programs accredited by the Accreditation Council for Graduate Medical Education, training thousands of physicians. Pioneering research has been conducted in areas like Alzheimer's disease, genomics, and COVID-19 therapeutics.

Affiliations and partnerships

The system maintains a strategic affiliation with the Veterans Health Administration through the Manhattan VA Medical Center. It is a founding member of the Mount Sinai Genomics Alliance and has significant international partnerships, including with Sheba Medical Center in Israel and Apollo Hospitals in India. Within New York City, it collaborates closely with the New York City Health and Hospitals Corporation and holds key contracts with Centers for Medicare & Medicaid Services. The system also partners with Northwell Health on certain regional initiatives.

Leadership and governance

The system is governed by a Board of Trustees chaired by prominent figures from the business and philanthropic communities, such as James S. Tisch. The President and CEO, a position held by Dr. Brendan Carr as of recent leadership, oversees the integrated network. The Dean of the Icahn School of Medicine at Mount Sinai, notably Dr. Dennis S. Charney, also plays a critical executive role. Overall governance and strategy are further guided by committees focusing on finance, quality, and academic affairs, ensuring alignment across its clinical and educational missions.

Category:Hospital networks in the United States Category:Healthcare in New York City Category:Medical and health organizations based in New York City